Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Torex Gold Moves Beyond Single-Asset Status With Reyna...

July 11, 2025

Patrick Tuohy: Gold’s Status Has Changed, Higher Price...

October 29, 2025

Gold Price 2025 Year-End Review

December 3, 2025

Editor’s Picks: Silver Price Breaks US$39 Again, Rare...

July 19, 2025

Allied Critical Metals Announces Receipt of Environmental Permit...

January 13, 2026

Growth Strategy Initiated with Option to Acquire Scandinavian...

November 29, 2025

Alvopetro Announces Q2 2025 Financial Results and an...

August 7, 2025

Operational Update

September 8, 2025

Angkor Shares For Debt Transaction

September 24, 2025

10 Biggest Cannabis Stocks in the US and...

January 13, 2026